Totally thoracoscopic closure of ventricular septal defect: A single-center clinical analysis
- VernacularTitle:全胸腔镜下室间隔缺损修补手术单中心临床分析
- Author:
LAN Huai
1
;
CHENG Yunge
2
;
JIA Baocheng
2
;
CHAI Yuliang
2
Author Information
1. Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, 110016, P.R.China
2. Department of Thoracoscopic Cardiacsurgery, Shanghai Yodak Cardiothoracic Hospital, Shanghai, 200235, P.R.China
- Publication Type:Journal Article
- Keywords:
Thoracoscopy;
minimally invasive cardiac surgery;
congenital heart disease;
ventricular septal defect
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(02):164-167
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the experience of totally thoracoscopic cardiac surgery for ventricular septal defect. Methods Clinical data of 449 patients undergoing totally thoracoscopic cardiac surgery for ventricular septal defect from May 2008 to December 2018 in Shanghai Yodak Cardiothoracic Hospital were analyzed retrospectively. There were 232 male and 217 female patients, aged from 3 to 55 years with a mean age of 17.3±11.2 years. Results All the operations were completed successfully. Mean operative time was 2.4±0.3 h. The mean extracorporeal circulation time and aortic cross-clamp time was 64.2±11.6 min and 28.4±10.7 min, respectively. Mechanical ventilation time and intensive care unit stay was 6.9±3.8 h and 20.5±5.6 h, respectively. Postoperation drainage quantity was 213.1±117.2 mL. The hospital stay was 6.9±1.3 d. Intraoperative and postoperative complications occurred in 11 patients (2.4%), including 1 patient of intraoperative reoperation, 3 patients of reoperation for bleeding, 3 patients of the incision infection, 2 patients of small residual shunt, 1 patient of right femoral artery incision stenosis complicated by thromboembolism and 1 patient of right pleural cavity pneumothorax. The mean follow-up time was 72.2±33.9 months. During the period, there was no reoperation, but 2 patients of ventricular septal defect small residual shunt, 1 patient of mild-moderate mitral valve and 1 patient of mild-moderate aortic valve incompetence, respectively. During the period, heart function of the patients was NYHAⅠ-Ⅱ. Conclusion Totally thoracoscopic cardiac surgery for ventricular septal defect is a safe and effective treatment, with few serious complications, fast recovery for patients and good short to medium-term outcomes.
